{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:50:11Z","timestamp":1761918611972,"version":"3.41.2"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1023\/b:ddas.0000037811.48575.da","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T21:06:10Z","timestamp":1092431170000},"page":"1190-1195","source":"Crossref","is-referenced-by-count":20,"title":["Survival of Anti-Mitochondrial Antibody-Positive and -Negative Primary Biliary Cirrhosis Patients on Ursodeoxycholic Acid Treatment"],"prefix":"10.1007","volume":"49","author":[{"given":"Meri","family":"Koulentaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Moscandrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipos","family":"Dimoulios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Costas","family":"Chatzicostas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias A.","family":"Kouroumalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"494221_CR1","first-page":"236","volume-title":"Diseases of the Liver and Biliary System","author":"S Sherlock","year":"1993","unstructured":"Sherlock S, Dooley J: Primary biliary cirrhosis. In Diseases of the Liver and Biliary System. Sherlock S, Dooley J (eds). Blackwell Scientific, Oxford, 1993, pp. 236\u2013248"},{"key":"494221_CR2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1478-3231.1999.tb00021.x","volume":"19","author":"H Kinoshita","year":"1999","unstructured":"Kinoshita H, Omagari K, Whittingham S, Kato Y, Ishibashi H, Sugi K, Yano M, Kohno S, Nakanuma Y, Penner E, Wesierska-Gadek J, Reynoso-Paz S, Gershwin ME, Anderson J, Jois JA, Mackay IR: Autoimmune cholangitis and primary biliary cirrhosis-an autoimmune enigma. Liver 19:122\u2013128, 1999","journal-title":"Liver"},{"key":"494221_CR3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/jhep.2001.27013","volume":"34","author":"N Ikuno","year":"2001","unstructured":"Ikuno N, Scealy M, Davies JM, Whittingham SF, Omagari K, Mackay IR, Rowley MJ: A comparative study of antibody expressions in primary biliary cirrhosis and autoimmune cholangitis using phage display. Hepatology 34:478\u2013486, 2001","journal-title":"Hepatology"},{"key":"494221_CR4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/gut.37.3.301","volume":"37","author":"AG Lim","year":"1995","unstructured":"Lim AG, Jazrawi PR, Northfield TC: The ursodeoxycholic acid stor y in primary biliary cirrhosis. Gut 37:301\u2013304, 1995","journal-title":"Gut"},{"key":"494221_CR5","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199405123301903","volume":"330","author":"RE Poupon","year":"1994","unstructured":"Poupon RE, Poupon R, Balkau B: Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 330:1342\u20131347, 1994 August 2004)","journal-title":"N Engl J Med"},{"key":"494221_CR6","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0016-5085(94)90021-3","volume":"106","author":"KD Lindor","year":"1994","unstructured":"Lindor KD, Dickson ER, Baldus WP, Jorgensen RA, Ludwig J, Murtaugh JM, Harrison JM, Wiesner RH, Anderson ML, Lange SM, LeSage G, Rossi SS, Hofmann AF: Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 106:1284\u20131290, 1994","journal-title":"Gastroenterology"},{"key":"494221_CR7","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/hep.1840190512","volume":"19","author":"EJ Heathcote","year":"1994","unstructured":"Heathcote EJ, Cauch-Dudek K, Walker V, Bailey RJ, Blendis LM, Ghent CN, Michieletti P, Minuk GY, Pappas SC, Scully LJ: The Canadian multicentre double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 19:1149\u20131156, 1994","journal-title":"Hepatology"},{"key":"494221_CR8","first-page":"759","volume":"22","author":"B Combes","year":"1995","unstructured":"Combes B, Carithers RL, Maddrey WC, Lin D, McDonnald MF, Wheeeler DE, Eigenbrodt EH, Munoz SJ, Rubin R, Garcia-Tsao G, Bonner GF, West AB, Boyer JL, Luketic VA, Shiffman ML, Mills AS, Peters MG, White HM, Zetterman RK, Rossi SS, Hoffman AF, Markin R: A randomized, double blind, placebo controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 22:759\u2013766, 1995","journal-title":"Hepatology"},{"key":"494221_CR9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0168-8278(00)80216-0","volume":"32","author":"A Pares","year":"2000","unstructured":"Pares A, Caballeria L, Rodes J, Bruguera M, Rodrigo L, Garcia-Plaza A, Berenguer J, Rodriguez-Martinez D, Mercader J, Velicia R: Long term effects of ursodeoxycholic acid in primary biliary cirrhosis: Results of a double-blind controlled multicentric trial. J Hepatol 32:561\u2013566, 2000","journal-title":"J Hepatol"},{"key":"494221_CR10","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","volume":"324","author":"RE Poupon","year":"1991","unstructured":"Poupon RE, Balkau B, Eschewege E, Poupon R: A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 324:1548\u20131554, 1991","journal-title":"N Engl J Med"},{"key":"494221_CR11","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1053\/jhep.2000.20240","volume":"32","author":"C Corpechot","year":"2000","unstructured":"Corpechot C, Carrat F, Bonnand AM, Poupon RE, Poupon R: The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary Biliary Cirrhosis. Hepatology 32:1196\u20131199, 2000","journal-title":"Hepatology"},{"key":"494221_CR12","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/j.1572-0241.2002.05923.x","volume":"97","author":"GV Papatheodoridis","year":"2002","unstructured":"Papatheodoridis GV, Hadziyannis ES, Deutsch M, Hadziyannis SJ: Ursodeoxycholic acid for primary biliary cirrhosis: Final results of a 12-year, prospective, randomized, controlled trial. Am J Gastroenterol 97:2063\u20132070, 2002","journal-title":"Am J Gastroenterol"},{"key":"494221_CR13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0168-8278(03)00192-2","volume":"39","author":"RE Poupon","year":"2003","unstructured":"Poupon RE, Lindor KD, Pares A, Chazouilleres O, Poupon R, Heathcote EJ: Combined analyses of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis. J Hepatol 39:12\u201316, 2003","journal-title":"J Hepatol"},{"key":"494221_CR14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","volume":"379","author":"J Ludwig","year":"1978","unstructured":"Ludwig J, Dickson ER, McDonald GSA: Staging of chronic nonsuppurative cholangitis (syndrome of primary biliary cirrhosis).Virchows Arch 379:103\u2013112, 1978","journal-title":"Virchows Arch"},{"key":"494221_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","volume":"10","author":"ER Dickson","year":"1989","unstructured":"Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Languorthy A: Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 10:1\u20137, 1989","journal-title":"Hepatology"},{"key":"494221_CR16","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1053\/gast.1996.v110.pm8613058","volume":"110","author":"KD Lindor","year":"1996","unstructured":"Lindor KD, Therneau TM, Jorgensen RA, Malinchoc M, Dickson ER: Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology 110:1515\u20131518, 1996","journal-title":"Gastroenterology"},{"key":"494221_CR17","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/S0016-5085(96)70051-3","volume":"111","author":"KD Lindor","year":"1996","unstructured":"Lindor KD, Therneau TM. Reply to letter: Survival in ursodeoxycholic acid-treated patients with biliary cirrhosis by Bonnand AM, Poupon RE. Gastroenterology 111:1782\u20131783, 1996","journal-title":"Gastroenterology"},{"key":"494221_CR18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/sim.4780100508","volume":"10","author":"BL Thompsen","year":"1991","unstructured":"Thompsen BL, Keiding N, Altman DG: A note on the calculation of expected survival, illustrated by the survival of liver transplant patients. Stat Med 10:733\u2013738, 1991","journal-title":"Stat Med"},{"key":"494221_CR19","first-page":"1527","volume":"11","author":"M. Voeth","year":"1992","unstructured":"Voeth M. Letter to the Editor. A note on the calculation of expected survival, illustrated by survival of liver transplant patients by Thomsen BL et al. Stat Med 11:1527\u20131532, 1992","journal-title":"A note on the calculation of expected survival, illustrated by survival of liver transplant patients by Thomsen BL et al. Stat Med"},{"key":"494221_CR20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"GL Kaplan","year":"1958","unstructured":"Kaplan GL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53: 457\u2013481, 1958","journal-title":"J Am Stat Assoc"},{"key":"494221_CR21","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2307\/2530150","volume":"37","author":"RF Woolson","year":"1981","unstructured":"Woolson RF: Rank tests and a one-sample log rank test for comparing observed survival data to a standard population. Biometrics 37: 632\u2013640, 1981","journal-title":"Biometrics"},{"key":"494221_CR22","unstructured":"Breslow NE, Day NE: The design and analysis of cohort studies.In Statistical Methods in Cancer Research. Vol. II. Lyon, France, IARC Scientific, 1980, pp. 49\u201369"},{"key":"494221_CR23","unstructured":"Hennekens CH, Buring JE: Epidemiology in Medicine. Boston, Little, Brown, 1987, pp. 82\u201385"},{"key":"494221_CR24","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","volume":"113","author":"RE Poupon","year":"1997","unstructured":"Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R, Heathcote EJ: Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 113:884\u2013890, 1997","journal-title":"Gastroenterology"},{"key":"494221_CR25","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(98)11293-X","volume":"354","author":"J Goulis","year":"1999","unstructured":"Goulis J, Leandro G, Burroughs AK: Randomized controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis. Lancet 354:1053\u20131060, 1999","journal-title":"Lancet"},{"key":"494221_CR26","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(05)72401-6","volume":"355","author":"KD Lindor","year":"2000","unstructured":"Lindor KD, Poupon RE, Poupon R, Heathcote EJ, Therneau T: Ursodeoxycholic acid for primary biliary cirrhosis. Lancet 355:657\u2013658, 2000","journal-title":"Lancet"},{"key":"494221_CR27","first-page":"CD000551","volume":"1","author":"C Gluud","year":"2002","unstructured":"Gluud C, Cristensen E: Ursodeoxycholic acid for primary biliary cirrhosis (Cochrane Review). Cochrane Database Syst Rev 1:CD000551, 2002","journal-title":"Cochrane Database Syst Rev"},{"key":"494221_CR28","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJM198906293202602","volume":"320","author":"BH Markus","year":"1989","unstructured":"Markus BH, Dickson ER, Grambsch PM, Fleming TR, Mazzaferro V, Klintmalm GB, Wiesner RH, Van Thiel DH, Starzl TE: Efficacy of liver transplantation in patients with primary biliary cirrhosis. N Eng J Med 320:1709\u20131713, 1989","journal-title":"N Eng J Med"},{"key":"494221_CR29","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/hep.510290603","volume":"29","author":"RE Poupon","year":"1999","unstructured":"Poupon RE, Bonnand AM, Chretien Y, Poupon R and the UDCAPBC Study group: Ten-year survival in ursodeoxycholic acid treated patients with primary biliary cirrhosis. Hepatology 29:1668\u20131671, 1999","journal-title":"Hepatology"},{"key":"494221_CR30","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.510300415","volume":"30","author":"P Krzeski","year":"1999","unstructured":"Krzeski P, Zych W, Kraszewska E, Milewski B, Botzuk E, Habior A: Is serum bilirubin concentration the only valid prognostic marker in primary biliary cirrhosis? Hepatology 30:865\u2013869, 1999","journal-title":"Hepatology"},{"key":"494221_CR31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1053\/jlts.2000.6503","volume":"6","author":"WR Kim","year":"2000","unstructured":"Kim WR, Wiesner RH, Poterucha JJ, Therneau TM, Benson JT, Kronn RA: Adaptation of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidates. Liver Transpl 6:489\u2013494, 2000","journal-title":"Liver Transpl"},{"key":"494221_CR32","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4065\/73.6.575","volume":"73","author":"RH Wiesner","year":"1998","unstructured":"Wiesner RH: Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: Predicting outcomes with natural history models. Mayo Clin Proc 73:575\u2013588, 1998","journal-title":"Mayo Clin Proc"},{"key":"494221_CR33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/gut.20.2.137","volume":"20","author":"JM Shapiro","year":"1979","unstructured":"Shapiro JM, Smith H, Schaffner F: Serum bilirubin: A prognostic factor in primary biliary cirrhosis. Gut 20:137\u2013140, 1979","journal-title":"Gut"},{"key":"494221_CR34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.510290140","volume":"29","author":"AM Bonnand","year":"1999","unstructured":"Bonnand AM, Heathcote EJ, Lindor KD, Poupon RE: Clinical significance of serum bilirium levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis. Hepatology 29:39\u201343, 1999","journal-title":"Hepatology"},{"key":"494221_CR35","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0025-6196(12)65350-6","volume":"64","author":"PM Grambsch","year":"1989","unstructured":"Grambsch PM, Dickson ER, Wiesner RH, Langworthy A: Application of the Mayo primary biliary cirrhosis survival model to Mayo liver transplant patients. Mayo Clin Proc 64:699\u2013704, 1989","journal-title":"Mayo Clin Proc"},{"key":"494221_CR36","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1053\/gast.2002.36027","volume":"123","author":"M Prince","year":"2002","unstructured":"Prince M, Chetwynd A, Newman E, Metcalf JV, James OFW: Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: Follow-up for up to 28 years.Gastroenterology 123:1044\u20131051, 2002","journal-title":"Gastroenterology"},{"key":"494221_CR37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0168-8278(03)00243-5","volume":"39","author":"G Paumgartner","year":"2003","unstructured":"Paumgartner G: Ursodeoxycholic acid for primary biliary cirrhosis: Treat early to slow progression. J Hepatol 39:112\u2013114, 2003","journal-title":"J Hepatol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:DDAS.0000037811.48575.da.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/B:DDAS.0000037811.48575.da\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:DDAS.0000037811.48575.da.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T03:31:03Z","timestamp":1753759863000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/B:DDAS.0000037811.48575.da"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":37,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["494221"],"URL":"https:\/\/doi.org\/10.1023\/b:ddas.0000037811.48575.da","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}